Pharvaris (PHVS) Other Operating Expenses (2021 - 2025)
Pharvaris (PHVS) posted Other Operating Expenses of -$0.0 for Q3 2025, up 100.0% on a QoQ basis from -$67.0 million in Q2 2025.
Pharvaris (PHVS) Other Operating Expenses (2021 - 2025) Analysis & Trends
Pharvaris' Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$0.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -67.03 Mn |
| Jun 30, 2024 | -49.68 Mn |
| Mar 31, 2024 | 0.00 |
| Jun 30, 2023 | -31.98 Mn |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | -29.28 Mn |
| Mar 31, 2022 | 0.00 |
| Sep 30, 2021 | 0.00 |